Zdrowie i gospodarka · 13/09/2023
FDA Withdraws Oxandrin Tablets Due to Safety and Effectiveness Concerns
The US Food and Drug Administration has determined that Oxandrin tablets in 2.5mg and 10mg doses were removed from sale due to concerns over safety and effectiveness, and will no longer accept new applications for these formulations.